Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses
Background: Gastric cancer (GC) is a prevalent malignant tumor of the digestive tract. Chemotherapy (CT) is the primary treatment for GC, but it is accompanied by toxic side effects. Several systematic reviews and meta-analyses (SRs/MAs) on the combination of Shenqi Fuzheng injection (SFI) with CT f...
Main Authors: | Jing Xu MD, PhD, Xiao Li MD, PhD, Qing Dong MD, PhD, Liyuan Lv MD, PhD, Zhangjun Yun MD, PhD, Li Hou MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-11-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354231210811 |
Similar Items
-
The role of Shenqi Fuzheng injection as adjuvant therapy for breast cancer: an overview of systematic reviews and meta-analyses
by: Jing Xu, et al.
Published: (2024-01-01) -
Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
by: Takeshi Kubota, MD, PhD, et al.
Published: (2022-03-01) -
Oncological Impact of Gross Proximal Margin Length in Distal Gastrectomy for Gastric Cancer: Is the Japanese Recommendation Valid?
by: Masaru Hayami, MD, PhD, et al.
Published: (2021-03-01) -
Minimum Esophageal Resection Length to Ensure Negative Proximal Margin in Total Gastrectomy for Gastric Cancer
by: Yasufumi Koterazawa, MD, PhD, et al.
Published: (2022-03-01) -
Shenqi Fuzheng injection alleviates chemotherapy-induced cachexia by restoring glucocorticoid signaling in hypothalamus
by: Entezar Berik, et al.
Published: (2024-03-01)